Novo Nordisk and Eli Lilly Address Weight Loss Drug Supply Issues
Good afternoon! All eyes are once again on Novo Nordisk and Eli Lilly as Wall Street looks for signs they…
Biotechnology and pharmaceuticals
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Eli Lilly (LLY) Q4 2023 Earnings
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
Novo Nordisk's parent company will buy Catalent to expand Wegovy supply
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
J&J, Merck and Bristol Myers Squibb on the bench
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Good afternoon!…
Non-opioid pain reliever Vertex shows positive results in late-stage trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston on Oct. 23, 2019. Brian Snyder | Reuters…
GSK sees huge RSV vaccine sales, raises outlook
The logo of pharmaceutical company GlaxoSmithKline is seen at its facility in Stevenage, Britain, October 26, 2020. Ruvic Dice |…
Biogen abandons Alzheimer's drug Aduhelm to focus on Leqembi, others
Biogen headquarters in Cambridge, Massachusetts, on October 24, 2023. vanessa leroy | Bloomberg | fake images biogen on Wednesday said…
Novo Nordisk Reaches $500 Billion in Market Value as It Points to Growing Demand for Wegovy and Ozempic
Liselotte Sabroe | afp | fake images Novo Nordisk on Wednesday reported better-than-expected profits for 2023 as sales of its…
Merck (MRK) 2023 Fourth Quarter Earnings Report
The Merck & Co. logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York…